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ABSTRACT
Background: Interleukin (IL)-4 and IL-13, which play
a role in the production of allergic inflammation, 
can activate fibroblasts to elicit a variety of cellular
functions. However, the effect of IL-4 and IL-13 on
fibronectin production by human lung fibroblasts (HLF)
has not been determined. In the present study, we
examined the effect of IL-4 and IL-13 on fibronectin
production by HLF in order to clarify these issues.
Methods: We stimulated HLF with various concentra-
tions of IL-4 and IL-13 for 12, 24, 48 and 72 h and
fibronectin concentrations in the culture supernatants
were determined by ELISA.
Results: The results showed that IL-4 and IL-13
induced fibronectin production in a time- and a
concentration-dependent manner. Anti-transforming
growth factor (TGF)-β1 antibody (ab) inhibited TGF-β1-
induced fibronectin production but not IL-4- and
IL-13-induced fibronectin production, indicating that
TGF-β1 is not involved in the IL-4- and IL-13-induced
fibronectin production by HLF.
Conclusions: These results indicate that IL-4 and 
IL-13 are capable of inducing fibronectin production
by HLF and play an important role in the production of
airway remodeling by inducing fibronectin production
as well as allergic inflammation.
Key words: fibronectin, human lung fibroblast,
interleukin-4, interleukin-13, remodeling.
INTRODUCTION
Airway remodeling has been documented to be a promi-
nent feature of the bronchial wall of patients with chronic
severe asthma.1–3 Many elements contribute to the air-
way remodeling response, which involves basement
membrane thickening associated with subepithelial extra-
cellular matrix deposition and subepithelial fibrosis.1–3
Bronchial asthma is a disease that is characterized by
episodic reversible airway obstruction, airway hyper-
responsiveness and allergic inflammation in the airway.4
T helper (h) 2 cytokines play a key role in the production of
allergic inflammation of asthma.5 Of the Th2 cytokines, it
has been demonstrated that the interleukin (IL)-4 and 
IL-13 receptors are expressed in fibroblasts6,7 and that IL-4
and IL-13 elicit various fibroblast cell functions, including
cytokine and adhesion molecule expression and extra-
cellular matrix protein synthesis.8–12 These observations
indicate that IL-4 and IL-13 play a role in the airway
remodeling response of asthma. Interleukin-4 has been
shown to induce fibronectin production by human synovial
fibroblasts from patients with rheumatoid arthritis and
osteoarthritis and infant dermal fibroblasts.8 However,
little is known about the effect of IL-4 on fibronectin pro-
duction by lung fibroblasts derived from healthy subjects.
Furthermore, the role of IL-13 in fibronectin production
has not been determined. Therefore, in the present study
clarified the role of IL-4 and IL-13 in fibronectin produc-
tion by examining the role of IL-4 and IL-13 in fibronectin
production by normal human lung fibroblasts (HLF). To
this end, we attempted to examine the effect of IL-13 as
well as IL-4 on fibronectin production by HLF.
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METHODS
Cells and reagents
Human lung fibroblasts were obtained from Clonetics
(San Diego, CA, USA). Human lung fibroblasts were
grown in a culture medium that was fibroblast growth
medium (FGM-2; Clonetics) containing 0.2% fetal
bovine serum (FBS), gentamycin–amphotericin B, fibro-
blast growth factor (FGF) and insulin. Interleukin-4 and
IL-13 were obtained from Endogen (Woburn, CA, USA)
and R&D Systems (Minneapolis, MN, USA), respectively.
Anti-transforming growth factor (TGF)-β1 antibody (ab;
clone 9016.2, mouse IgG1), anti-IL-13 ab (clone
32116.11, mouse IgG1) and IL-5 were obtained from
Genzyme Techne (Minneapolis, MN, USA). The anti-IL-4
ab (clone 34019.111, mouse IgG2b) and isotype-
matched control mouse IgG1 and IgG2 were obtained
from Sigma Chemical Co. (St Louis, MO, USA).
Cell cultures
For the determination of fibronectin production, cells
were placed onto collagen-coated 24-well flat-bottomed
tissue culture plates (Iwaki, Tokyo, Japan) and cultured
using culture medium at 37°C in a humidified 5% CO2
atmosphere. When cells had grown to subconfluency, 
the culture medium was replaced with FGM-2 medium
without FBS, FGF and insulin (growth factor-free medium)
for 16 h. In order to determine fibronectin production by
IL-4- and IL-13-stiumlated HLF, cells were stimulated with
various concentrations of IL-4 and IL-13 and cultured for
various lengths of time, as indicated. The examine the
effects of anti-TGF-β1 ab on IL-4- and IL-13-induced
fibronectin production, cells that had been incubated
with anti-TGF-β1 ab for 1 h were stimulated with IL-4 or 
L-13 and cultured.
Measurement of fibronectin and TGF-β1
The concentrations of fibronectin in the culture super-
natants from HLF were measured by commercially
available ELISA kits (Chemicon International, Temecula,
CA, USA). The concentrations of TGF-β1 in culture 
supernatants from HLF were measured by commercially
available ELISA kits (Genzyme Techne). The minimum
detectable concentration of TGF-β1 was 7 pg/mL. 
The ELISA was performed according to the manu-
facturer’s instructions. All samples were assayed in
duplicate.
Statistical analysis
Statistical significance was analyzed using analysis of
variance (ANOVA). P < 0.05 was considered significant.
RESULTS
Interleukin-4 and IL-13 induce fibronectin
production in a time-dependent manner
First, we examined the time-dependent effects of IL-4 and
IL-13 on fibronectin production by HLF. To this end, 
the culture supernatants from HLF stimulated with 
100 ng/mL IL-4 or 100 ng/mL IL-13 were harvested at
12, 24, 48 and 72 h after cultivation. The concentration
of fibronectin in the culture supernatants from IL-4-
stimulated HLF increased at 12 h, was maximal at 48 h
and decreased at 72 h (Fig. 1). Similarly, the concentra-
tion of fibronectin in culture supernatants from
IL-13-stimulated HLF increased in a time-dependent
manner (Fig. 1). In order to establish the specificity of the
regulatory effect of IL-4 and IL-13 on fibronectin produc-
tion, HLF that had been incubated with anti-IL-4 ab or
anti-IL-13 ab were stimulated with IL-4 or IL-13 and the
concentration of fibronectin in the culture supernatants
Fig. 1 Interleukin (IL)-4 and IL-13 induce fibronectin pro-
duction in a time-dependent manner. Human lung fibroblasts
(HLF) were cultured with medium (), 100 ng/mL IL-4 () or
100 ng/mL IL-13 () and cultured for 12, 24 and 48 h. The
concentration of fibronectin in culture supernatants was deter-
mined by ELISA. The results are expressed as the mean ± SD of
five experiments. *P < 0.01 compared with the concentration
of fibronectin in culture supernatants from HLF cultured with
medium.
was then determined at 48 h. At 50 µg/mL anti-IL-4 ab, a
concentration that was sufficient for neutralizing IL-4
activity (500 ng/mL), fibronectin production by IL-4-stim-
ulated HLF was abolished. Similarly, 50 µg/mL anti-IL-13
ab, which was sufficient for neutralizing IL-13 activity 
(500 ng/mL), abolished fibronectin production by IL-13-
stimulated HLF. Isotype-matched control mouse IgG had
no effect on fibronectin production by IL-4- and IL-13-
stimulated HLF (data not shown). These results establish
the specificity of the regulatory effect of these cytokines on
fibronectin production.
IL-4 and IL-13 induce fibronectin production
in a concentration-dependent manner
In the next series of experiments, we examined the
concentration-dependent effects of IL-4 and IL-13 on
fibronectin production by HLF. To this end, culture super-
natants from HLF stimulated with various concentrations
of IL-4 or IL-13 were harvested at 48 h after cultivation.
The concentration of fibronectin in culture supernatants
from IL-4-stimulated HLF increased in a concentration-
dependent manner when HLF were stimulated with
0.1–100 ng/mL IL-4 (Fig. 2). When HLF were stimulated
with 500 ng/mL IL-4, fibronectin production was not
enhanced further. Similar observations were obtained 
for IL-13-stimulated HLF (Fig. 2). Interleukin-5 did not
induce fibronectin production by HLF (data not shown).
Transforming growth factor-β1 induces
fibronectin production and a combination of
TGF-β1 and IL-4 or IL-13 additively induces
fibronectin production
The concentration of fibronectin in culture supernatants
from TGF-β1-stimulated HLF at 48 h after cultivation
increased in a concentration-dependent manner (Fig. 3).
When cells were stimulated with a combination of TGF-β1
(10 ng/mL) and IL-4 (100 ng/mL), TGF-β1 and IL-4 addi-
tively induced fibronectin production (Fig. 4). Similar
observations were obtained for HLF cultures stimulated
with TGF-β1 (10 ng/mL) and IL-13 (100 ng/mL; Fig. 4).
In contrast, when cells were stimulated with a combina-
tion of IL-4 (100 ng/mL) and IL-13 (100 ng/mL), the
concentration of fibronectin in culture supernatants from
HLF stimulated with IL-4 and IL-13 was comparable to
that from HLF stimulated with IL-4 or IL-13 alone (Fig. 4).
Human lung fibroblasts were stimulated with TGF-β1
(10 ng/mL) in the presence of anti-TGF-β1 ab and it 
was observed that anti-TGF-β1 ab abolished the effects of
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Fig. 3 Transforming growth factor (TGF)-β1 induces fibro-
nectin production. Human lung fibroblasts (HLF) were cultured
for 48 h with medium () or various concentrations of TGF-β1
(). The concentration of fibronectin in culture supernatants
was determined by ELISA. The results are expressed as the
mean ± SD of five experiments. *P < 0.01 compared with
fibronectin concentrations in culture supernatants from HLF
cultured with medium.
Fig. 2 Interleukin (IL)-4 and IL-13 induce fibronectin pro-
duction in a concentration-dependent manner. Human lung
fibroblasts (HLF) were cultured for 48 h with medium () or
various concentrations of IL-4 () or IL-13 (). The concentra-
tion of fibronectin in culture supernatants was determined by
ELISA. The results are expressed as the mean ± SD of five
experiments. *P < 0.05, †P < 0.01 compared with fibronectin
concentrations in culture supernatants from HLF cultured with
medium.
TGF-β1 on fibronectin production. When HLF were stimu-
lated with IL-4 (100 ng/mL) or IL-13 (100 ng/mL) in the
presence of anti-TGF-β1 ab, anti-TGF-β1 ab did not affect
IL-4- and IL-13-induced fibronectin production (Fig. 5).
In addition, the concentration of TGF-β1 in IL-4- and 
IL-13-stimulated cultures was below the sensitivity limits
of the assay (data not shown). The concentration of anti-
TGF-β1 ab used in the present study (100 µg/mL) was
sufficient to neutralize TGF-β1 activity (100 ng/mL).
Isotype-matched control mouse IgG had no effect on
fibronectin production by TGF-β1-, IL-4- and IL-13-
stimulated HLF (data not shown).
DISCUSSION
In the present study, we attempted to clarify the role of 
IL-4 and IL-13 in airway remodeling by examining the
effect of IL-4 and IL-13 on fibronectin production by HLF.
We focused on the effect of these cytokines on fibronectin
production by HLF because an increased deposition of
fibronectin has been shown at the site of airway remodel-
ing.1,13 The results of the present study showed that 
IL-4 induced fibronectin production in a time- and
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Fig. 4 A combination of transforming growth factor (TGF)-β1
and interleukin (IL)-4 or IL-13 additively induces fibronectin
production. Human lung fibroblasts (HLF) were stimulated 
with TGF-β1 (10 ng/mL) and either IL-4 (100 ng/mL) or IL-13
(100 ng/mL) and cultured for 48 h. The concentration of
fibronectin in culture supernatants was determined by ELISA.
The results are expressed as the mean ± SD of five experi-
ments. *P < 0.01 compared with fibronectin concentrations in
culture supernatants from HLF cultured with IL-4 or IL-13 alone
and P < 0.05 compared with fibronectin concentrations in
culture supernatants from HLF cultured with TGF-β1 only.
Fig. 5 Anti-transforming growth factor (TGF)-β1 antibody (ab) inhibits TGF-β1- but not IL-4- and IL-13-induced fibronectin pro-
duction. Human lung fibroblasts (HLF) that had been incubated with a sufficient concentrations of anti-TGF-β1 ab for neutralizing
TGF-β1 were stimulated with TGF-β1 (10 ng/mL), IL-4 (100 ng/mL) or IL-13 (100 ng/mL) and cultured for 48 h. The concentration
of fibronectin in culture supernatants was determined by ELISA. The results are expressed as the mean ± SD of five experiments. 
*P < 0.01 compared with fibronectin concentrations in culture supernatants from HLF cultured with TGF-β1.
concentration-dependent manner. Similar observations
were obtained for IL-13-stimulated HLF. Interleukin-13
shares many functional activities with IL-4 and uses similar
receptor subunits for signaling.6,14 Interleukin-4 has been
shown to induce fibronectin production by fibroblastic cell
lines.8 The results of the present study showed that IL-4
was capable of inducing fibronectin production by HLF as
well as fibroblastic cell lines and that IL-13 had a similar
activity to IL-4 in inducing fibronectin production by HLF. In
addition, when HLF were stimulated with a combination of
IL-4 and IL-13, an additive effect was not seen. These
results indicate that IL-4 and IL-13 use a common pathway
to induce fibronectin production by HLF.
Because TGF-β1 is known to induce fibronectin pro-
duction by fibroblasts,15,16 TGF-β1 may be responsible 
for the induction of fibronectin production by IL-4- and 
IL-13-stimulated HLF. To test this possibility, we examined
the effect of anti-TGF-β1 ab on fibronectin production 
by IL-4- and IL-13-stimulated cultures and measured
TGF-β1 concentrations in IL-4- and IL-13-stimulated cul-
tures. The results were as follows: (i) anti-TGF-β1 ab did
not affect IL-4- and IL-13-induced fibronectin production;
and (ii) the concentration of TGF-β1 in IL-4- and IL-13-
stimulated cultures was below the sensitivity limits of the
assay. These results indicate that IL-4 and IL-13 are
capable of inducing fibronectin production by HLF and
that TGF-β1 is not involved in the IL-4- and IL-13-induced
production of fibronectin by HLF.
It is generally accepted that the airway remodeling
response is preceded by allergic inflammation and that
Th2 cytokines, such as IL-4 and IL-13, play a key role in
the production of allergic inflammation.5,13 Several lines
of study have suggested that IL-4 and IL-13 play a role in
the development of airway remodeling. Interleukin-4 and
IL-13 can activate fibroblasts to elicit a variety of cellular
functions, including extracellular matrix production.8–12
Pulmonary overexpression of IL-13 causes allergic
inflammation and subepithelial fibrosis17 and IL-13
inhibitors block the development of fibrogenic process.18
In addition to this evidence, the present results with IL-4-
and IL-13-induced production of fibronectin by HLF
indicate that IL-4 and IL-13 may play a role in the devel-
opment of fibrogenic processes in airway remodeling 
by inducing fibronectin production by HLF. We simul-
taneously examined the effect of another Th2 cyto-
kine, namely IL-5, on fibronectin production by HLF.
Interleukin-5 did not induce fibronectin production,
indicating that IL-4 and IL-13, but not all Th2 cytokines,
can induce fibronectin production by HLF.
The pathogenesis of airway remodeling is complex.
Multiple inflammatory cells, cytokines and mediators
participate in the pathogenesis of airway remodeling.
Fibroblasts are involved in the development of fibrogenic
process in airway remodeling by producing extracellular
matrix. Therefore, an understanding of the mechanism 
of fibronectin production would suggest a strategy 
for therapy to control the development of fibrogenic
processes in airway remodeling in bronchial asthma.
From the data presented here, we conclude that 
the Th2 cytokines IL-4 and IL-13 play an important role 
in the production of airway remodeling by inducing
fibronectin production by HLF, as well as allergic
inflammation.
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